INTELLIA THERAPEUTICS INC (NTLA) Stock Income Statement
USA - NASDAQ:NTLA - US45826J1051 - Common Stock
8.24 USD
-0.23 (-2.72%)
8.48 USD
+0.24 (+2.91%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 57.53M | 57.88M | 36.27M | 52.12M | 33.05M | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 536.25M | 592.14M | 551.57M | 510.29M | 300.90M | |||
| Research and Development | 417.09M | 466.31M | 435.07M | 419.98M | 229.81M | |||
| Selling, General, and Administrative Expenses | 119.17M | 125.83M | 116.50M | 90.31M | 71.10M | |||
| Operating Income | -478.73M | -534.26M | -515.29M | -458.16M | -267.85M | |||
| Interest Income/Expense | 32.92M | 15.24M | 34.20M | -2.54M | -40.00K | |||
| Other Income/Expense | null | 0 | -100.00K | -13.49M | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -445.81M | -519.02M | -481.19M | -474.19M | -267.89M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -445.81M | -519.02M | -481.19M | -474.19M | -267.89M | |||
| EBITDA | -466.25M | -523.98M | -506.32M | -450.59M | -260.96M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -4.2656 | -5.2506 | -5.4207 | -6.16 | -3.78 | |||
| Non GAAP EPS | -4.27 | -5.250000000000001 | -5.41 | -6.18 | -3.7600000000000002 | |||
| Statistics | ||||||||
| Profit Margin | -774.94% | -896.77% | -1326.51% | -909.80% | -810.56% | |||
| Operating Profit Margin | -832.16% | -923.10% | -1420.51% | -879.05% | -810.44% | |||
All data in USD